Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 59.21
- Piotroski Score 3.00
- Grade Buy
- Symbol (TRML)
- Company Tourmaline Bio, Inc.
- Price $25.00
- Changes Percentage (0.6%)
- Change $0.15
- Day Low $23.85
- Day High $25.26
- Year High $48.31
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 10/20/2023
- Dividend Payable N/A
- Today N/A
- Next Earnings (Estimated) 11/12/2024
- Fiscal Year End N/A
- Average Stock Price Target $72.00
- High Stock Price Target $74.00
- Low Stock Price Target $50.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $-42,124,000